Latest Breaking News On - Kiryat matalon - Page 2 : comparemela.com

Can Fite BioPharma : Financial results for the six months ended June 30, 2023 and updates on its drug development programs and an unaudited interim condensed consolidated financial statements as of June 30, 2023. -Today at 09:30 am

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of.

Form 6-K Can-Fite BioPharma Ltd. For: Aug 24

Can Fite BioPharma : Immediate Report -Today at 07:26 am

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of.

Can Fite BioPharma : NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 31, 2023

NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 31, 2023 To the shareholders of Can-Fite BioPharma Ltd.: Notice is hereby given that the 2023 Annual General Me.

Can Fite BioPharma : Other Report or Announcement

. | April 21, 2023